Aortic Stenosis Treatment and guidelines

Interventional options and guidelines are continually evolving in aortic stenosis (AS). Access the key updates on aortic stenosis management in the 2021 ESC/EACTS guidelines, including the evidence that supported this change and the importance of a shared decision-making process with your patients.

2021 ESC/EACTS guidelines in practice

TF-TAVI is now a Class IA recommendation, for patients with severe aortic stenosis (sAS) ≥75 years of age**, as well as for additional patient groups < 75 years of age.1 Read more about the changes and how they could impact your everyday clinical practice.
**Based on evaluation of clinical, anatomical and procedural factors
ESC-EACTS guidelines

Diagnosing aortic stenosis patients

The ESC/EACTS guidelines continue to recommend echocardiography as a key tool in confirming AS diagnosis and severity, guiding treatment choices and indicating when intervention is needed.1

Interventional options for aortic valve replacement (AVR)

The updated 2021 ESC/EACTS Guidelines for the treatment of sAS highlight the role of the Heart Team and patient choice on treatment decisions.1


Find out more about the current treatment options for your patients with sAS, and considerations of the Heart Team when deciding between TAVI and surgery (SAVR).

Transfemoral TAVI (TF-TAVI) procedure using balloon-expandable technology with SAPIEN 3 Platform

Interventional options for aortic valve replacement (AVR)

The updated 2021 ESC/EACTS Guidelines for the treatment of sAS highlight the role of the Heart Team and patient choice on treatment decisions.1


Find out more about the current treatment options for your patients with sAS, and considerations of the Heart Team when deciding between TAVI and surgery (SAVR).

Transfemoral TAVI (TF-TAVI) procedure using balloon-expandable technology with SAPIEN 3 Platform

Stay informed with our newsletter

Our monthly updates provide you the latest developments in TAVI and aortic stenosis.     Read more

References

  • 1Vahanian A, et al. Eur Heart J. 2021; ehab395. doi:10.1093/eurheartj/ehab395.
Content relating to Tavi.today is intended for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.
Skip to content